删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Novel systemic therapeutic for nasopharyngeal carcinoma (2012)_香港中文大学

香港中文大学 辅仁网/2017-06-28

Novel systemic therapeutic for nasopharyngeal carcinoma
Publication in refereed journal


香港中文大学研究人员 ( 现职)
马碧如教授 (肿瘤学系)
陈林教授 (肿瘤学系)


全文


引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/14WOS source URL

其它资讯

摘要Introduction: Systemic therapy is crucial to the management of locally advanced or metastatic nasopharyngeal cancer (NPC). Despite initial responses, the benefits of conventional chemotherapy are seldom durable and the toxicities are intolerable to most patients. Therefore, novel therapies based on molecular targets of NPC have become the focus of development.

着者Chan SL, Ma BB
期刊名称EXPERT OPINION ON THERAPEUTIC TARGETS
出版年份2012
月份3
日期1
卷号16
出版社Taylor & Francis: STM, Behavioural Science and Public Health Titles
页次S63 - S68
国际标準期刊号http://aims.cuhk.edu.hk/converis/portal/Publication/1472-8222
电子国际标準期刊号1744-7631
语言英式英语

关键词angiogenesis; epidermal growth factor receptor; epigenetic; nasopharyngeal cancer
Web of Science 学科类别Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY

相关话题/肿瘤 国际 语言 电子 香港中文大学